TransCode Therapeutics (NASDAQ:RNAZ) announced that the National Institutes of Health (NIH) has awarded the company a $2 million Direct to Phase II Small Business Innovation Research grant to support the clinical...
Tag - RNAZ
Copyright © 2024 BioTuesday Publishing Corporation - Privacy Policy